Home / CNN.com - RSS Channel - App International Edition / Alzheimer's drug lecanemab receives accelerated approval in US amid safety concerns

Alzheimer's drug lecanemab receives accelerated approval in US amid safety concerns

January 06, 2023 CNN.com - RSS Channel - App International Edition

The US Food and Drug Administration granted accelerated approval Friday for the Alzheimer's disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline.

from CNN.com - RSS Channel - App International Edition https://ift.tt/KCyshRN

No comments

Subscribe to: Post Comments ( Atom )